
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Conflict Of Interest from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/conflict-of-interest/topic/2085/</link>
        <description>Articles tagged with Conflict Of Interest from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Researchers find schools minting pitch-resistant docs</title>
          <description>A BMJ study finds that medical school gift bans make doctors less likely to prescribe a new drug. Also of note: consumers think money motivates some doctors&apos; recommendations.</description>
          <link>http://www.mmm-online.com/researchers-find-schools-minting-pitch-resistant-docs/article/278972/</link>
          <pubDate>Mon, 04 Feb 2013 19:01:35 GMT</pubDate>
          <itunes:summary>A BMJ study finds that medical school gift bans make doctors less likely to prescribe a new drug. Also of note: consumers think money motivates some doctors&apos; recommendations.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>CMS releases &quot;Sunshine&quot; final rule: federal preemption, August start date</title>
          <description>CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.</description>
          <link>http://www.mmm-online.com/cms-releases-sunshine-final-rule-federal-preemption-august-start-date/article/278783/</link>
          <pubDate>Fri, 01 Feb 2013 21:20:35 GMT</pubDate>
          <itunes:summary>CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>GSK&apos;s Connelly: We&apos;ve changed our ways (and please don&apos;t imprison execs)</title>
          <description>GlaxoSmithKline&apos;s Dierdre Connelly peeled back the curtain on the company&apos;s sales force incentives revamp in a speech to the Pharmaceutical Regulatory and Compliance Congress, and pleaded for recognition that the industry had cleaned up the sketchy practices of the Blockbuster Era.</description>
          <link>http://www.mmm-online.com/gsks-connelly-weve-changed-our-ways-and-please-dont-imprison-execs/article/267037/</link>
          <pubDate>Mon, 05 Nov 2012 20:56:09 GMT</pubDate>
          <itunes:summary>GlaxoSmithKline&apos;s Dierdre Connelly peeled back the curtain on the company&apos;s sales force incentives revamp in a speech to the Pharmaceutical Regulatory and Compliance Congress, and pleaded for recognition that the industry had cleaned up the sketchy practices of the Blockbuster Era.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Medtronic defends physician ties IDed in Senate report</title>
          <description>Medtronic rebuffed Senate Finance Committee charges that the company ghostwrote or influenced journal articles about its InFuse bone-growth product while conspiring to paper over adverse events from the treatment.</description>
          <link>http://www.mmm-online.com/medtronic-defends-physician-ties-ided-in-senate-report/article/265881/</link>
          <pubDate>Mon, 29 Oct 2012 14:33:00 GMT</pubDate>
          <itunes:summary>Medtronic rebuffed Senate Finance Committee charges that the company ghostwrote or influenced journal articles about its InFuse bone-growth product while conspiring to paper over adverse events from the treatment.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Docs downgrade results of pharma-funded clinical trials</title>
          <description>Physicians take pharma-sponsored clinical trials with a grain of salt, a study published in The New England Journal of Medicine has found.</description>
          <link>http://www.mmm-online.com/docs-downgrade-results-of-pharma-funded-clinical-trials/article/259981/</link>
          <pubDate>Thu, 20 Sep 2012 16:52:40 GMT</pubDate>
          <itunes:summary>Physicians take pharma-sponsored clinical trials with a grain of salt, a study published in The New England Journal of Medicine has found.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Sunshine Act could scare docs away from commercially-supported CME</title>
          <description>Physicians are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will tarnish their reputations and fuel perceptions of conflicts of interest, a survey has found.</description>
          <link>http://www.mmm-online.com/sunshine-act-could-scare-docs-away-from-commercially-supported-cme/article/258904/</link>
          <pubDate>Thu, 13 Sep 2012 18:01:28 GMT</pubDate>
          <itunes:summary>Physicians are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will tarnish their reputations and fuel perceptions of conflicts of interest, a survey has found.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Makers of pain pills, advocacy groups at center of Senate probe</title>
          <description>The Senate Finance Committee is looking to crack down on unnecessary pain prescriptions and is using a money trail to do it.</description>
          <link>http://www.mmm-online.com/makers-of-pain-pills-advocacy-groups-at-center-of-senate-probe/article/240387/</link>
          <pubDate>Wed, 09 May 2012 18:40:40 GMT</pubDate>
          <itunes:summary>The Senate Finance Committee is looking to crack down on unnecessary pain prescriptions and is using a money trail to do it.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Journal &quot;pharmascolds&quot; skew policy, says study</title>
          <description>Medical journal coverage of the question of physician-industry relationships is &quot;unbalanced&quot; and may be skewing public policy towards ever-more restrictive safeguards against industry influence.</description>
          <link>http://www.mmm-online.com/journal-pharmascolds-skew-policy-says-study/article/236332/</link>
          <pubDate>Thu, 12 Apr 2012 20:56:25 GMT</pubDate>
          <itunes:summary>Medical journal coverage of the question of physician-industry relationships is &quot;unbalanced&quot; and may be skewing public policy towards ever-more restrictive safeguards against industry influence.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Require disclosure of pharma ties, most docs say</title>
          <description>The majority of physicians agrees that it&apos;s important to disclose to patients any financial relationships with drug and device companies but, research shows, there remains considerable rearguard sentiment to transparency.</description>
          <link>http://www.mmm-online.com/require-disclosure-of-pharma-ties-most-docs-say/article/227749/</link>
          <pubDate>Tue, 14 Feb 2012 20:58:11 GMT</pubDate>
          <itunes:summary>The majority of physicians agrees that it&apos;s important to disclose to patients any financial relationships with drug and device companies but, research shows, there remains considerable rearguard sentiment to transparency.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Despite decline, ghostwriting in papers still common: study</title>
          <description>Researchers analyzing the prevalence of ghostwriting in leading medical journals over more than a decade saw a decline but found inappropriate authorship remained all too common.</description>
          <link>http://www.mmm-online.com/despite-decline-ghostwriting-in-papers-still-common-study/article/215257/</link>
          <pubDate>Tue, 25 Oct 2011 17:18:00 GMT</pubDate>
          <itunes:summary>Researchers analyzing the prevalence of ghostwriting in leading medical journals over more than a decade saw a decline but found inappropriate authorship remained all too common.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  